Moreover, recent studies have revealed that CD109 is overexpressed in multiple human cancers, including squamous cell carcinoma of the lung [92], vulva [93] and uterine cervix [94], adenosquamous carcinoma of the gallbladder [95], and ductal adenocarcinoma of the pancreas [96]. Here, CD109 is linked to cancer.